VKTX: Viking Therapeutics Inc. Stocks News on April 2, 2025

VKTX

Simply Wall St.

2 days ago

Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month

VKTX

Zacks

6 days ago

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

VKTX

Zacks

6 days ago

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

VKTX

Investor's Business Daily

7 days ago

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

PR Newswire

7 days ago

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

Zacks

8 days ago

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

VKTX

Motley Fool

10 days ago

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

VKTX

Motley Fool

13 days ago

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

VKTX

Motley Fool

14 days ago

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

VKTX

Simply Wall St.

16 days ago

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement

VKTX

Zacks

19 days ago

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

VKTX

Zacks

20 days ago

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

VKTX

Zacks

20 days ago

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

VKTX

Insider Monkey

20 days ago

Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

VKTX

Motley Fool

21 days ago

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

B. Riley sees two key positives in Viking manufacturing agreement

VKTX

TipRanks

21 days ago

B. Riley sees two key positives in Viking manufacturing agreement

VKTX

Zacks

21 days ago

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply

Viking strikes $150m deal to secure supply of obesity drug

VKTX

Pharmaceutical Technology

22 days ago

Viking strikes $150m deal to secure supply of obesity drug

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

VKTX

Investor's Business Daily

22 days ago

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

Stellantis, Tesla, Viking Therapeutics: Market Minute

VKTX

Yahoo Finance Video

22 days ago

Stellantis, Tesla, Viking Therapeutics: Market Minute

Viking Therapeutics closer to bringing its Ozempic competitor to market

VKTX

Quartz

22 days ago

Viking Therapeutics closer to bringing its Ozempic competitor to market

VKTX

MT Newswires

22 days ago

Update: Viking Therapeutics Shares Fall After Manufacturing Deal With CordenPharma

H.C. Wainwright says Novo results support Viking obesity potential

VKTX

TipRanks

22 days ago

H.C. Wainwright says Novo results support Viking obesity potential

VKTX

Zacks

22 days ago

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

VKTX

MT Newswires

22 days ago

Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

VKTX

PR Newswire

22 days ago

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

VKTX

Motley Fool

24 days ago

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

VKTX

Zacks

25 days ago

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

VKTX

Insider Monkey

a month ago

Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday

Viking Therapeutics to Participate at Upcoming Investor Conferences

VKTX

PR Newswire

a month ago

Viking Therapeutics to Participate at Upcoming Investor Conferences

VKTX

Simply Wall St.

a month ago

Viking Therapeutics (NasdaqCM:VKTX) Reports US$35M Q4 Loss As Stock Falls 12%

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

VKTX

Investor's Business Daily

a month ago

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

VKTX

Insider Monkey

a month ago

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

1 Biotech Stock to Buy in 2025, and 1 to Avoid

VKTX

Motley Fool

a month ago

1 Biotech Stock to Buy in 2025, and 1 to Avoid

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

VKTX

Motley Fool

a month ago

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

VKTX

Insider Monkey

a month ago

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

VKTX

Motley Fool

a month ago

Is Viking Therapeutics a Buy Right Now?

Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect

VKTX

Zacks

a month ago

Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect

VKTX

Insider Monkey

a month ago

Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now

VKTX

Zacks

a month ago

Should You Buy VKTX Stock Amid Renewed M&A Speculations?

Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

VKTX

Motley Fool

a month ago

Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

VKTX

Insider Monkey

a month ago

Why Viking Therapeutics Inc. (VKTX) Surged On Friday?

VKTX

Insider Monkey

a month ago

Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?

VKTX

MT Newswires

2 months ago

Scotiabank Initiates Viking Therapeutics at Sector Outperform

VKTX

Insider Monkey

2 months ago

Why Viking Therapeutics Inc. (VKTX) Went Down on Monday

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

VKTX

Motley Fool

2 months ago

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

VKTX

Motley Fool

2 months ago

2 Stocks to Buy With Less Than $40

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

VKTX

Motley Fool

2 months ago

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

The M&A boom of 2025 is just getting started — and here are 5 potential targets

VKTX

MarketWatch

2 months ago

The M&A boom of 2025 is just getting started — and here are 5 potential targets

Viking Therapeutics price target lowered to $96 from $109 at B. Riley

VKTX

TipRanks

2 months ago

Viking Therapeutics price target lowered to $96 from $109 at B. Riley

VKTX

Motley Fool

2 months ago

2 Stocks That Could Soar Again in 2025

Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?

VKTX

Motley Fool

2 months ago

Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?

VKTX

MT Newswires

2 months ago

B. Riley Adjusts Price Target on Viking Therapeutics to $96 From $109, Keeps Buy Rating

VKTX

MT Newswires

2 months ago

Citigroup Initiates Viking Therapeutics at Neutral With $38 Price Target

VKTX

MT Newswires

2 months ago

Truist Securities Adjusts Viking Therapeutics Price Target to $95 From $120, Maintains Buy Rating

The Drug Industry Is Having Its Own DeepSeek Moment

VKTX

The Wall Street Journal

2 months ago

The Drug Industry Is Having Its Own DeepSeek Moment

Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why.

VKTX

Investor's Business Daily

2 months ago

Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why.

Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials

VKTX

GuruFocus.com

2 months ago

Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials

Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.

VKTX

Investor's Business Daily

2 months ago

Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.

VKTX

Zacks

2 months ago

VKTX's Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%

Has the Bubble Burst for Viking Therapeutics Stock?

VKTX

Motley Fool

2 months ago

Has the Bubble Burst for Viking Therapeutics Stock?

VKTX

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Viking Therapeutics Inc Earnings Call

VKTX

GuruFocus.com

2 months ago

Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...

VKTX

Insider Monkey

2 months ago

Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers

Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

VKTX

PR Newswire

2 months ago

Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

VKTX

Zacks

2 months ago

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?

VKTX

Insider Monkey

2 months ago

Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?

VKTX

Insider Monkey

2 months ago

Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”

This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?

VKTX

Motley Fool

2 months ago

This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?

VKTX

Insider Monkey

2 months ago

Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

VKTX

Zacks

2 months ago

Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

VKTX

Investor's Business Daily

2 months ago

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results

VKTX

Investor's Business Daily

2 months ago

Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results

This Weight-Loss Drug Stock Could Gain 200%. The Case for It to Challenge Novo, Lilly.

VKTX

Barrons.com

2 months ago

This Weight-Loss Drug Stock Could Gain 200%. The Case for It to Challenge Novo, Lilly.

This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?

VKTX

Motley Fool

2 months ago

This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know

VKTX

Quartz

2 months ago

The race for the next Ozempic is on

VKTX

Zacks

2 months ago

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

VKTX

Insider Monkey

2 months ago

Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today

VKTX

Motley Fool

3 months ago

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today

VKTX

Insider Monkey

3 months ago

Why Viking Therapeutics (VKTX) Is the Biotech Stock with Biggest Upside Potential

VKTX

Zacks

3 months ago

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

VKTX

BioPharma Dive

3 months ago

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday

VKTX

Motley Fool

3 months ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday

VKTX

Zacks

3 months ago

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

VKTX

Investor's Business Daily

3 months ago

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment

VKTX

Clinical Trials Arena

3 months ago

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

VKTX

Zacks

3 months ago

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

3 Mid-Cap Stocks That Could Take Off in 2025

VKTX

Motley Fool

3 months ago

3 Mid-Cap Stocks That Could Take Off in 2025

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

PR Newswire

3 months ago

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

Zacks

3 months ago

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know

Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

VKTX

PR Newswire

3 months ago

Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Why Viking Therapeutics Stock Plummeted by 24% in December

VKTX

Motley Fool

3 months ago

Why Viking Therapeutics Stock Plummeted by 24% in December

VKTX

Zacks

3 months ago

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

From Davids to Goliaths: the GLP-1RA gold rush

VKTX

Pharmaceutical Technology

3 months ago

From Davids to Goliaths: the GLP-1RA gold rush

Should You Buy the Dip on This High-Flying Stock?

VKTX

Motley Fool

3 months ago

Should You Buy the Dip on This High-Flying Stock?

VKTX

Zacks

3 months ago

VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?

VKTX

Insider Monkey

3 months ago

Latest Viking Therapeutics Inc. (VKTX) News on April 2, 2025

Share on Social Networks: